A research team has developed a three-dimensional neural electrode that deforms smoothly using soft actuation technology. It is expected to be used in various next-generation soft bioelectronic ...

OKYO Pharma has filed a Fast Track designation application with the Food and Drug Administration (FDA) for urcosimod in the treatment of neuropathic ...

Despite its increasing prevalence, a painful condition called bladder pain syndrome, or interstitial cystitis, remains ...

Urcosmid is a lipid conjugated chemerin peptide agonist of the ChemR23 G-protein coupled receptor, typically found on immune ...

Fast track was first introduced by FDA to expedite development and review of drugs to treat serious conditions lacking any FDA-approved drug,” commented Gary S. Jacob, Ph.D., Chief Executive Officer ...

OKYO Pharma (OKYO) announces the filing of its application for Fast Track designation, FTD, with the U.S. Food and Drug Administration, FDA, ...

Other drugs, like gabapentin and venlafaxine, are also used for nerve pain, but more research is needed to compare their ...

This achievement leverages the pain-relieving properties of cannabis without inducing mind-altering side effects. The compound has been tested in mice with some positive results. The study highlights ...

Damage or injury to nerves causes a painful condition called neuropathy. This article reviews the safety and evidence behind ...

For decades, the mainstream remedy against chronic pain has been waged with a double-edged sword: opioids. These powerful ...

Tris Pharma, Inc. (Tris), a commercial-stage biopharmaceutical company, today announced positive topline results from its ...